Sepsis Diagnostics Market Generate Around USD 792 Million by 2025

Sarasota, FL -- (SBWire) -- 03/21/2019 --According to the report, the global sepsis diagnostics market was valued at approximately USD 441 million in 2018 and is expected to generate around USD 792 million by 2025, at a CAGR of around 8.70% between 2019 and 2025.

Sepsis is a life-threatening condition caused by bacterial infection. This disease injures the tissues and organs. As per physicians, it is a three-staged syndrome disease—sepsis, severe sepsis, and septic shock. Severe sepsis is associated with acute alteration in the mental status and organ dysfunction, whereas septic shock is defined as severe sepsis with signs of rapidly falling blood pressure, organ dysfunction, and abnormalities in cellular metabolism, all of which are considered as medical emergencies.

DOWNLOAD FREE PDF BROCHURE @ http://bit.ly/2HAkTjN

The increasing demand for antibiotic-resistant bacterial strains and growing incidences of hospital-acquired infections are likely to boost the sepsis diagnostics market globally in the future. The rising incidences of HAI's (hospital-acquired infections) are anticipated to be the major growth driver of the global sepsis diagnostics market in the upcoming years. HAIs trigger sepsis mainly in individuals who have weak immunity or are at an increased risk of being diagnosed with chronic diseases.

The global sepsis diagnostics market is segmented on the basis of product, technology, pathogen type, method, and test type. By product type, the market is segmented into blood culture media, assay kits and reagents, and instruments. Blood culture media is likely to hold the largest share of the sepsis diagnostics market over the forecast timeline, owing to the huge demand for cost-effective and standard methods of testing by clinicians. The technology segment includes immunoassays, microbiology, microfluidics, molecular diagnostics, biomarkers, and flow cytometry. The microbiology segment is likely to dominate the sepsis diagnostics market globally in the future, owing to its ability to determine microorganisms for sepsis diagnosis via culture media test applications quantitatively. By pathogen type, the sepsis diagnostics market includes fungal sepsis, bacterial sepsis, and others. The bacterial sepsis segment is further segmented into gram-negative bacteria and gram-positive bacteria. The bacterial sepsis segment held the largest market share in 2017, as most patients are affected by gram-negative bacterial sepsis. Furthermore, the fungal sepsis segment is likely to register the highest CAGR in the future, due to the high prevalence of Candida infection resulting in septic poisoning among the patients. By the method, the sepsis diagnostics market includes automated diagnostics and conventional diagnostics. The conventional diagnostics segment held the largest market share in 2017, owing to its cost-effectiveness and ability to make timely changes for appropriate therapy. By test type, the market is bifurcated into laboratory tests and point-of-care tests. Laboratory tests held the maximum market share in 2017, as a large number of blood culture tests are conducted in laboratories.

By region, North America is anticipated to dominate the sepsis diagnostics market globally and hold a major share over the forecast timeline. This can be attributed to the growing adoption of advanced and new diagnostic techniques, rising demand for better healthcare facilities, increasing incidences of chronic diseases, such as diabetes, cancer, etc. leading to increased hospital admissions, and high per capita healthcare expenditure. The Asia Pacific region is projected to register the highest CAGR over the estimated timeframe, owing to the rise in geriatric population, rapidly expanding healthcare infrastructure, and an increase in the prevalence of chronic diseases in China, India, and Australia.

Get FREE Sample Research Report @ http://bit.ly/2W7uKkb

Some leading players of the global sepsis diagnostics market are Danaher, Immunexpress, Biomerieux, Thermo Fisher Scientific, Becton, Dickinson, and Company, Response Biomedical, Bruker, Luminex, Roche Diagnostics, and T2 Biosystems.

This report segments the global sepsis diagnostics market into:

Global Sepsis Diagnostics Market: Product Analysis

Instruments
Blood Culture Media
Assay Kits and Reagents

Global Sepsis Diagnostics Market: Technology Analysis

Microbiology
Molecular Diagnostics
Immunoassays
Flow Cytometry
Microfluidics
Biomarkers
Global Sepsis Diagnostics Market: Pathogen Type Analysis

Bacterial Sepsis
Gram-Positive Bacteria
Gram-Negative Bacteria
Fungal Sepsis
Others

Global Sepsis Diagnostics Market: Method Analysis

Conventional Diagnostics
Automated Diagnostics

Global Sepsis Diagnostics Market: Test Type Analysis

Laboratory Tests
Point-Of-Care Tests

Global Sepsis Diagnostics Market: Regional Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

GET FREE PDF BROCHURE @ http://bit.ly/2HAkTjN

About Zion Market Research
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.